OBJECTIVE: The objective of this study was to determine if magnesium sulfate's central anticonvulsant activity is effective against N-methyl-D-aspartate-induced seizures. STUDY DESIGN: In two separate experiments we investigated magnesium sulfate's ability to inhibit N-methyl-D-aspartate-induced hippocampal seizures in rats. In the first experiment magnesium sulfate was administered peripherally before an intracranial injection of 20 micrograms of N-methyl-D-aspartate. In the second experiment magnesium sulfate was injected intracranially concurrently with N-methyl-D-aspartate. The ability of magnesium sulfate to suppress N-methyl-D-aspartate-induced seizure activity under both conditions was assessed. RESULTS: Peripherally administered magnesium sulfate significantly increased the latency from the time of an N-methyl-D-aspartate injection to the first seizure both by acute injection and after 2 hours of sustained elevation of serum magnesium levels when compared with saline solution-injected controls (p < 0.01). The duration of the first seizure was also significantly reduced. Intracranially administered magnesium sulfate significantly (p < 0.01) increased the seizure latency period by 120%. Overall, central magnesium sulfate prevented seizure activity in 40% of the animals (p < 0.01). CONCLUSION: Magnesium sulfate has a central anticonvulsant action on N-methyl-D-aspartate-induced seizures in this rat model of hippocampal seizures.
OBJECTIVE: The objective of this study was to determine if magnesium sulfate's central anticonvulsant activity is effective against N-methyl-D-aspartate-induced seizures. STUDY DESIGN: In two separate experiments we investigated magnesium sulfate's ability to inhibit N-methyl-D-aspartate-induced hippocampal seizures in rats. In the first experiment magnesium sulfate was administered peripherally before an intracranial injection of 20 micrograms of N-methyl-D-aspartate. In the second experiment magnesium sulfate was injected intracranially concurrently with N-methyl-D-aspartate. The ability of magnesium sulfate to suppress N-methyl-D-aspartate-induced seizure activity under both conditions was assessed. RESULTS: Peripherally administered magnesium sulfate significantly increased the latency from the time of an N-methyl-D-aspartate injection to the first seizure both by acute injection and after 2 hours of sustained elevation of serum magnesium levels when compared with saline solution-injected controls (p < 0.01). The duration of the first seizure was also significantly reduced. Intracranially administered magnesium sulfate significantly (p < 0.01) increased the seizure latency period by 120%. Overall, central magnesium sulfate prevented seizure activity in 40% of the animals (p < 0.01). CONCLUSION:Magnesium sulfate has a central anticonvulsant action on N-methyl-D-aspartate-induced seizures in this rat model of hippocampal seizures.
Authors: Laura Bennet; Robert Galinsky; Vittoria Draghi; Christopher A Lear; Joanne O Davidson; Charles P Unsworth; Alistair J Gunn Journal: J Physiol Date: 2018-04-16 Impact factor: 5.182
Authors: Nicole Pages; Pierre Maurois; Bernadette Delplanque; Pierre Bac; Jean-Charles Martin; Qin Du; Stanley I Rapoport; Joseph Vamecq Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2011-06-12 Impact factor: 4.006
Authors: Rui Zhang; Timothy D Bryson; Garrett M Fogo; Jinhui Liao; Sarita Raghunayakula; Jennifer Mathieu; Joseph M Wider; Xiaodan Ren; Kathleen J Maheras; Katlynn J Emaus; Erin Gruley; Yuguo Chen; Robert W Neumar; Thomas H Sanderson Journal: Mol Neurobiol Date: 2022-01-14 Impact factor: 5.590
Authors: Matthew T Flavin; Marek A Paul; Alexander S Lim; Charles A Lissandrello; Robert Ajemian; Samuel J Lin; Jongyoon Han Journal: Proc Natl Acad Sci U S A Date: 2022-06-02 Impact factor: 12.779